Search Results - Manikhas, A.

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4) by Martín, M., Chan, Arlene, Dirix, L., O'Shaughnessy, J., Hegg, R., Manikhas, A., Shtivelband, M., Krivorotko, P., Batista López, N., Campone, M., Ruiz Borrego, M., Khan, Q., Beck, J., Ramos Vázquez, M., Urban, P., Goteti, S., Di Tomaso, E., Massacesi, C., Delaloge, S.

Get full text